News-Medical.Net May 4, 2023
Sponsored Content by BGI Genomics Reviewed by Olivia Frost

In this interview, Dr. Stephen Lye, the Interim Director of the Lunenfeld-Tanenbaum Research Institute at Sinai Health, talks to NewsMedical about how AI and DNA sequencing can be used for understanding pregnancy complications.

Please introduce yourself and your role at the Lunenfeld-Tanenbaum Research Institute at Sinai Health? What inspired your career – both in science and in maternal health?

My name is Dr. Stephen Lye, and I am the interim director of the Lunenfeld-Tanenbaum Research Institute at Sinai Health, which is part of the University of Toronto. My interest in maternal child health can be attributed to when I undertook my post-doctoral training in London, Ontario.

I am originally from Bristol, England, but I moved to Canada to do...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: AI (Artificial Intelligence), Interview / Q&A, Patient / Consumer, Pharma / Biotech, Precision Medicine, Provider, Technology, Trends
Related Articles:
Seniors deserve timely access to care, not bureaucratic hurdles | Viewpoint
From Noise To Clarity, Here’s An Empowering Way To Hearing Health
Why doctors increasingly turn away from rural clinical practice
More than half of US adults could benefit from GLP-1 medications, researchers find
Concerns raised over Indiana hospital merger

Share This Article